In summary, reducing HDAC6 levels has been shown to improve cognitive function and synaptic dysfunction in AD models, making HDAC6 inhibition a promising therapeutic strategy for treating cognitive decline in AD. The gene discussed is HDAC6; the disease is Mental deterioration.